Rickettsia conorii, the etiologic agent of Mediterranean spotted fever (MSF), is a Gram-negative, obligate intracellular bacterial pathogen transmitted to humans via arthropod vectors. As one of the prototypical species belonging to the spotted fever group (SFG) rickettsiae, R. conorii displays tropism for microvascular endothelium during human infections and in a well-established animal model of infection and robust actinbased directional motility for intracellular movements and intercellular spread. Compared to Rocky Mountain spotted fever, caused by R. rickettsii, MSF has traditionally been considered a relatively milder disease, with clinical symptoms of fever, headache, and maculopapular rash. Mainly because of delays in diagnosis and timely start of doxycycline therapy, however, MSF can result in significant morbidity and mortality. More recently, a severe form of MSF has also been reported, supported by evidence of vascular lesions in kidneys, gastrointestinal tract, liver, spleen, and skin and complications leading to meningoencephalitis, Guillain-Barré syndrome, hypoxemia, multiorgan failure, and death (25,26,28,34,35,46). A clinical study of severe MSF cases in Algeria documented a fatality rate as high as 54.5% among the patients with multiorgan involvement of the disease, despite implementation of treatment with antibiotics (26). In spite of their global distribution and the resurgence of human rickettsial infections, the mechanisms underlying the virulence and pathogenesis of this group of diseases remain poorly characterized.Infection with SFG rickettsiae activates otherwise quiescent vascular endothelium to acquire a procoagulant and proinflammatory phenotype by inducing the expression and/or secretion of a variety of cytokines and chemokines as well as surface adhesion molecules (17,37,42). As essential immunoregulators, interferons (IFNs) have also been demonstrated to play an important role in host innate and adaptive immune responses during bacterial infections. Upon production and secretion in response to microbial stimuli, type I interferons activate IFN-inducible genes, which in turn modulate the innate host defense to establish an antimicrobial state in infected cells. In comparison to the existing and rapidly expanding literature on the manipulation of IFN signaling by viruses, the knowledge of how IFN-inducible genes provide protection against bacterial pathogens is lagging far behind. Further, there is no published evidence on whether or not Rickettsiainfected endothelium is capable of secreting IFNs, and the potential roles of IFN-mediated cell signaling in host defense remain completely unknown.To regulate host immunomodulatory genes, interferons trig-